# Wang Ji

> Wang Ji is a Series A investor at Longpan Investment backing Medical and Biopharma. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Longpan Investment](https://shizune.co/investors/profile/longpan-investment)
- Total investments: 3
- Last investment: Dec 2025
- Lead investor: 67%
- Last updated: Aug 2026

Wang Ji is a Series A investor at Longpan Investment focused on Medical and Biopharma. Wang Ji is the Vice President of Longpan Investment.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 100% |
| Biopharma | 2 | 67% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Manufacturing | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Seed | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SynRx Therapeutics | Sanctuary Bio is a DNA damage repair drug developer, focusing on the field of DNA damage repair. | $14.1M | Series A | Dec 08, 2025 |  |
| Phrontline Biopharma | Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology. | $60M | Seed | Nov 21, 2025 |  |
| BioTroy Therapeutics | BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine. | $27.8M | Series A | Jun 17, 2025 |  |

3 of 3 investments shown.

## Co-investors
- [Cowin Venture](https://shizune.co/investors/profile/cowin-venture) — VC Fund, 1 deal together
- [Decheng Capital](https://shizune.co/investors/profile/decheng-capital) — VC Fund, 1 deal together
- [Guofang Innovation](https://shizune.co/investors/profile/guofang-innovation) — VC Fund, 1 deal together
- [Haibang Capital](https://shizune.co/investors/profile/haibang-capital) — VC Fund, 1 deal together
- [Hangzhou Talent Group](https://shizune.co/investors/profile/hangzhou-talent-group) — VC Fund, 1 deal together
- [Hankang Capital](https://shizune.co/investors/profile/hankang-capital) — VC Fund, 1 deal together

## About Longpan Investment

VC Fund · Beijing, China

Longpan Investment is an investment firm.

1 contacts available at Longpan Investment.

| Name | Title | Profile |
| --- | --- | --- |
| Wang Ji | Vice President | https://shizune.co/investors/profile/wang-ji |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Wang Ji invest in?

Wang Ji invests primarily in Medical, Biopharma and Health Care startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Wang Ji last invest?

The most recent investment recorded for Wang Ji closed in Dec 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co